Skilarence 30 mg, 120 mg gastro-resisistant tablets
- Name:
Skilarence 30 mg, 120 mg gastro-resisistant tablets
- Company:
Almirall Limited
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may be renewed (B)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 15/10/20
(Click to Download)Click on this link to Download PDF directly
Almirall Limited
Company Products
| Medicine Name | Active Ingredients |
|---|---|
| Medicine Name Almogran 12.5 mg Film-coated tablet | Active Ingredients Almotriptan D, L-hydrogen malate |
| Medicine Name Ilumetri 100 mg solution for injection in pre-filled syringe | Active Ingredients Tildrakizumab |
| Medicine Name Meptid 100 mg/ml Solution for Injection | Active Ingredients Meptazinol hydrochloride |
| Medicine Name Meptid 200 mg Film-Coated Tablets | Active Ingredients Meptazinol hydrochloride |
| Medicine Name Skilarence 30 mg gastro-resistant tablets | Active Ingredients Dimethyl fumarate |
| Medicine Name Skilarence 30 mg, 120 mg gastro-resisistant tablets | Active Ingredients Dimethyl fumarate |
| Medicine Name Solaraze 3% Gel | Active Ingredients Diclofenac Sodium |
| Medicine Name Vaniqa 11.5% cream | Active Ingredients Eflornithine hydrochloride monohydrate |
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 15 October 2020 PIL
Reasons for updating
- Change to section 4 - possible side effects
Free text change information supplied by the pharmaceutical company
Additional side effect with frequency unknown: herpes zoster
Updated on 15 October 2020 SPC
Reasons for updating
- Change to Section 4.8 – Undesirable effects - how to report a side effect
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Section 4.8 - additional side effect - Herpes zoster
Removal of astericks to indicate that the following side effects have also been reported for Skilarence:
PML, abdominal distention, allergic skin reaction, proteinuria, renal failure, serum creatininine increased.
Updated on 18 November 2019 Ed-HCP
Reasons for updating
- Replace document
Free text change information supplied by the pharmaceutical company
Update of email address for queries
Updated on 22 August 2019 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Addition of 70 and 120 tablet pack size for the 30 mg strength.
Updated on 13 February 2019 Ed-HCP
Reasons for updating
- Add New Doc
Updated on 30 January 2019 PIL
Reasons for updating
- New PIL for new product
Skilarence Risk Minimisation MaterialRisk Minimisation Materials
(Click to Download)
Educational Materials for Medicines
Educational Materials for Medicines